Acute bacterial skin and skin structure infections (ABSSSI) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSI are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, two new lipoglycopeptides, in the context of the other I.V. available standard therapy options.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.NPR.0000515428.68779.87 | DOI Listing |
Publication Analysis
Top Keywords
acute bacterial
8
bacterial skin
8
skin skin
8
skin structure
8
structure infections
8
managing acute
4
skin
4
infections focus
4
focus lipoglycopeptides
4
lipoglycopeptides acute
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!